Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Revenue (2016 - 2025)

Bio-Techne has reported Revenue over the past 17 years, most recently at $295.9 million for Q4 2025.

  • Quarterly results put Revenue at $295.9 million for Q4 2025, changed 0.39% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (up 1.64% YoY), and the annual figure for FY2025 was $1.2 billion, up 5.23%.
  • Revenue for Q4 2025 was $295.9 million at Bio-Techne, up from $286.6 million in the prior quarter.
  • Over the last five years, Revenue for TECH hit a ceiling of $317.0 million in Q2 2025 and a floor of $2.0 million in Q3 2022.
  • Median Revenue over the past 5 years was $288.8 million (2022), compared with a mean of $271.9 million.
  • Biggest five-year swings in Revenue: tumbled 99.22% in 2022 and later surged 13746.75% in 2023.
  • Bio-Techne's Revenue stood at $269.3 million in 2021, then increased by 0.86% to $271.6 million in 2022, then rose by 0.37% to $272.6 million in 2023, then rose by 8.96% to $297.0 million in 2024, then decreased by 0.39% to $295.9 million in 2025.
  • The last three reported values for Revenue were $295.9 million (Q4 2025), $286.6 million (Q3 2025), and $317.0 million (Q2 2025) per Business Quant data.